We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
(+7.6%)
Cap. Flow
+$567M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$82.7M |
| 2 |
PepsiCo
PEP
|
+$76.8M |
| 3 |
Marriott International
MAR
|
+$64.8M |
| 4 |
Tyson Foods
TSN
|
+$62.8M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$64.8M |
| 2 |
Hormel Foods
HRL
|
+$61.4M |
| 3 |
Gilead Sciences
GILD
|
+$59.9M |
| 4 |
Hilton Worldwide
HLT
|
+$54.7M |
| 5 |
TechnipFMC
FTI
|
+$51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.71% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DF
826
DELISTED
Dean Foods Company
DF
| $539K | ﹤0.01% |
32,892
+2,685
| +9% | +$46.9K |
|
|
MBFI
827
DELISTED
MB Financial Corp
MBFI
| $539K | ﹤0.01% |
14,178
| – | – |
|
|
MGLN
828
DELISTED
Magellan Health Services, Inc.
MGLN
| $536K | ﹤0.01% |
9,980
+9,630
| +2,751% | +$580K |
|
829
American Eagle Outfitters
AEO
$2.85B
| $524K | ﹤0.01% |
29,385
-64
| -0.2% | -$1.15K |
|
830
Diamondrock Hospitality Co
DRH
$2.63B
| $524K | ﹤0.01% |
57,706
+57,009
| +8,179% | +$556K |
|
|
CBM
831
DELISTED
Cambrex Corporation
CBM
| $524K | ﹤0.01% |
11,816
-34
| -0.3% | -$1.65K |
|
832
Insperity
NSP
$1.85B
| $523K | ﹤0.01% |
14,410
| – | – |
|
833
Innospec
IOSP
$2.09B
| $518K | ﹤0.01% |
8,528
| – | – |
|
|
GSJ.CL
834
DELISTED
The Goldman Sachs Group Inc
GSJ.CL
| $518K | ﹤0.01% |
20,284
| – | – |
|
835
White Mountains Insurance
WTM
$5.47B
| $517K | ﹤0.01% |
624
+71
| +13% | +$58.5K |
|
|
BPL
836
DELISTED
Buckeye Partners, L.P.
BPL
| $516K | ﹤0.01% |
7,228
-1,822
| -20% | -$130K |
|
837
iShare MSCI Eurozone ETF
EZU
$9.41B
| $513K | ﹤0.01% |
14,885
-10,900
| -42% | -$367K |
|
838
New Mountain Finance
NMFC
$646M
| $511K | ﹤0.01% |
37,206
-27,373
| -42% | -$374K |
|
839
Digital Realty Trust
DLR
$73.7B
| $510K | ﹤0.01% |
5,273
-1,681
| -24% | -$171K |
|
|
INN
840
Summit Hotel Properties
INN
$761M
| $508K | ﹤0.01% |
+38,645
| New | +$535K |
|
841
Everest Group
EG
$15.2B
| $501K | ﹤0.01% |
2,644
+100
| +4% | +$18.8K |
|
842
Employers Holdings
EIG
$908M
| $499K | ﹤0.01% |
16,757
| – | – |
|
|
ONCE
843
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $498K | ﹤0.01% |
8,302
+3,302
| +66% | +$190K |
|
844
APA Corp
APA
$12.8B
| $495K | ﹤0.01% |
7,772
-189
| -2% | -$10.3K |
|
845
Trip.com Group
TCOM
$27.5B
| $495K | ﹤0.01% |
10,646
+3,389
| +47% | +$151K |
|
846
Chemed
CHE
$6.78B
| $494K | ﹤0.01% |
3,503
-45
| -1% | -$6.26K |
|
|
FMBI
847
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $488K | ﹤0.01% |
25,239
| – | – |
|
848
CF Industries
CF
$19.2B
| $487K | ﹤0.01% |
20,081
+8,039
| +67% | +$196K |
|
|
BRKL
849
DELISTED
Brookline Bancorp
BRKL
| $484K | ﹤0.01% |
39,763
| – | – |
|
850
OGE Energy
OGE
$10.3B
| $482K | ﹤0.01% |
15,281
-1,560
| -9% | -$49.4K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2016 Portfolio in Review
As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.
- Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
- Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
- Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
- Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
- Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
- Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
- Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.
Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.